Target intelligence / Profile preview

Relaxin-3 (RLN3)

Target
RLN3
Molecular classification
Peptide hormone, Neuropeptide, Member of the relaxin/insulin superfamily
01

Overview

Relaxin-3 (RLN3) is a highly conserved neuropeptide hormone in the relaxin/insulin superfamily, consisting of two chains (A and B), with major expression in the nucleus incertus of the brainstem[1][2][3][4][5]. Functioning primarily through the relaxin family peptide 3 receptor (RXFP3), relaxin-3 is a key modulator of arousal, stress response, feeding/metabolism, and cognitive processes, with broad neuronal projections throughout the extended limbic system and septohippocampal pathways[1][2][3][4]. Its role in the central nervous system implicates it as a promising target for neuropsychiatric, stress-related, and metabolic disorders, including depression, anxiety, and addiction, with ongoing research into RXFP3 agonists and antagonists as potential therapeutic agents [1][2][3][4][5].

Other names
Relaxin-3Relaxin-3 B chainRelaxin-3 A chainRLN3INSL7RXN3ZINS4Insulin-like peptide 7H3Prorelaxin H3insl7
02

Mechanism of action

Agonists: Mimic relaxin-3 action on RXFP3 receptor, activating downstream signaling involved in neural modulation. Antagonists: Block relaxin-3 activity at RXFP3, potentially modulating stress, feeding, or arousal pathways.

03

Biological functions

Neuropeptide signalingModulation of arousalStress response regulationFeeding/metabolic regulationCognition and memory modulation
04

Disease associations

Neuropsychiatric disease (especially anxiety and depression)Feeding disordersAutism spectrum disorderDrug addiction
05

Safety considerations

Broad involvement in neural circuits may pose challenges for selectivity and off-target CNS effectsInsufficient data on long-term modulation of RXFP3/relaxin-3 system
06

Interacting drugs

Experimental RXFP3 agonists (e.g., R3-B10-27)

1 more in the full profile.

Beyond the preview

Go deeper on Relaxin-3 (RLN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relaxin-3 (RLN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call